109820 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
GENEMATRIX, Inc. engages in the development of platform and molecular diagnostics products. Its products include pharmaceutical products for respiratory, sexually transmitted, human papillomavirus, and gastrointestinal infections. The company was founded on December 7, 2000 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
109820 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company